Lupin's Generic Colitis Drug Infringes Patents, Pharmas Say
Cosmo Technologies Ltd. and a Salix Pharmaceuticals Ltd. subsidiary sued in Delaware federal court Friday to block Lupin Ltd.'s abbreviated new drug application for a generic version of the colitis treatment...To view the full article, register now.
Already a subscriber? Click here to view full article